OzEAN Study to Collect Real-World Evidence of Persistent Use, Effectiveness, and Safety of Ozanimod Over 5 Years in Patients With Relapsing-Remitting Multiple Sclerosis in Germany

MS Treatments

Jahr

Publikationsjahr
2022

Autoren

Autorenliste der Publikation
Ziemssen T, Richter S, Mäurer M, Buttmann M, Kreusel B, Poehler AM, Lampl M, Linker RA.

Verlag

Publisher-Information
Front Neurol. 2022 Jun 27;13:913616.

Link

Zur Publikation (externer Server)
https://doi.org/10.3389/fneur.2022.913616

Tags

Forschungsthemen
Multiple SkleroseMS BehandlungManagement & Science
MSZTreatmentsMASC2022